Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Ibandronate Sodium

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Ibandronate Sodium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 915Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Adjuvant Ibandronate Plus Capecitabine Does Not Significantly Improve OS
    Adjuvant Ibandronate Plus Capecitabine Does Not Significantly Improve OS

    07 Jul 2023

    // ONCLIVE

    https://www.onclive.com/view/adjuvant-ibandronate-plus-capecitabine-does-not-significantly-improve-os-in-elderly-patients-with-early-breast-cancer

    ONCLIVE
    07 Jul 2023
    Share Share
    Nang Kuang Pharm's Generic Ibandronate Sodium Receives Approval In US
    Nang Kuang Pharm's Generic Ibandronate Sodium Receives Approval In US

    21 Jun 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204329

    FDA
    21 Jun 2021
    Share Share
    Macleods Pharm’s Generic Ibandronate Sodium Receives Approval In US
    Macleods Pharm’s Generic Ibandronate Sodium Receives Approval In US

    01 Nov 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206887

    FDA
    01 Nov 2017
    Share Share
    Aurobindo Pharma's Generic Ibandronate Sodium approved in US for treatment of osteoporosis
    Aurobindo Pharma's Generic Ibandronate Sodium approved in US for treatment of osteoporosis

    11 Mar 2016

    // FDA

    https://www.pharmacompass.com/pdf/news/aurobindo-pharmas-generic-ibandronate-sodium-approved-in-us-for-treatment-of-osteoporosis-1458041719.pdf

    FDA
    11 Mar 2016
    Share Share
    Chugai Pharma receives Japanese approval for steoporosis drug, Bonviva tablet
    Chugai Pharma receives Japanese approval for steoporosis drug, Bonviva tablet

    23 Jan 2016

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=93001&sid=2

    PHARMABIZ
    23 Jan 2016
    Share Share
    8 Invented Diseases Big Pharma Is Banking On
    8 Invented Diseases Big Pharma Is Banking On

    02 Feb 2015

    // Martha Rosenberg ALTERNET

    http://www.alternet.org/personal-health/8-invented-diseases-big-pharma-banking

    Martha Rosenberg ALTERNET
    02 Feb 2015
    Share Share